[1]
G. E. Pérez Figueroa, A. Guevara-Salinas, D. Álvarez -Luquín, and L. Adalid Peralta, “Dopaminergic agonists and L-DOPA, used to treat Parkinson’s disease, induce dopamine receptor expression on immune cells”, Arch Neurocien, vol. 29, no. S1, Apr. 2024.